Foto del docente

Barbara Monti

Professoressa ordinaria

Dipartimento di Farmacia e Biotecnologie

Settore scientifico disciplinare: BIO/09 FISIOLOGIA

Direttrice Dipartimento di Farmacia e Biotecnologie

Pubblicazioni

Nicola Marini, Andrea Miti, Francesca De Chirico, Francesca Massenzio, Sabrina Petralla, Barbara Monti, Giampaolo Zuccheri, Tampering with microglia-mediated neuroinflammation by means of DNA nanostructures, in: AA.VV., Abstract booklet for DNA Nanotechnology 2022: “DNA hybrid structures”, Jena, 2022, pp. 42 - 42 (atti di: DNA Nanotechnology 2022: “DNA hybrid structures”, Jena, Germany, 12-14/05/2022) [atti di convegno-abstract]

Coordinamento del progetto: Telethon GGP19067-2019 - "Alla ricerca di nuovi bersagli terapeutici per contrastare l’ipomielinizzazione nell’AGC1 deficiency: uno studio multidisciplinare sui precursori delle cellule cerebrali"..

Martina Fazzina, Francesca Massenzio, Barbara Monti, Matteo Bergonzoni, Davide Maestri, Flavia Frabetti, Raffaella Casadei, Up-regulation of LINC00520 in in vitro models of Parkinson's disease: searching for a physiological role and dysregulation in neurodegeneration, in: Abstract book - XX Congresso Nazionale A.I.B.G. - Roma, 23-24 Settembre 2022, 2022, pp. 62 - 62 (atti di: XX Congresso Nazionale A.I.B.G., Roma, 23-24 Settembre 2022) [atti di convegno-abstract]

Sabrina Petralla, Cristina Parenti, Valentina Ravaioli, Irene Fancello, Francesca Massenzio, Marco Virgili, Barbara Monti, Emiliano Pena-Altamira, Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia, «MOLECULAR NEUROBIOLOGY», 2021, 58, Article number: 19, pp. 1312 - 1329 [articolo]

Martina Fazzina, Letizia Pruccoli, Andrea Tarozzi, Francesca Massenzio, Barbara Monti, Davide Maestri, Matteo Bergonzoni, Flavia Frabetti, Raffaella Casadei, Dysregulation of long non-coding RNAs in neuroinflammation: characterization of LINC00520 and its possible role in Parkinson's disease, in: 2nd International Conference on Neuroprotection by Drugs, Nutraceuticals, and Physical Activity, 2021, pp. 35 - 35 (atti di: 2nd International Conference on Neuroprotection by Drugs, Nutraceuticals, and Physical Activity, Virtual edition, 9-10 dicembre 2021) [atti di convegno-abstract]

Sabrina Petralla, Francesca De Chirico, Andrea Miti, Ottavia Tartagni, Francesca Massenzio, Eleonora Poeta, Marco Virgili, Giampaolo Zuccheri, Barbara Monti, Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches, «BIOMOLECULES», 2021, 11, Article number: 306, pp. 1 - 28 [articolo]Open Access

Albertini C.; Naldi M.; Petralla S.; Strocchi S.; Grifoni D.; Monti B.; Bartolini M.; Bolognesi M.L., From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease, «MOLECULES», 2021, 26, Article number: 1112, pp. 1 - 22 [articolo]Open Access

Ruolo editoriale nella rivista «Guest editor della special Issue "Microglia in neurodegeneration" nella sezione "Molecular Biology" della rivista Biomolecules»

He F.; Chou C.J.; Scheiner M.; Poeta E.; Yuan Chen N.; Gunesch S.; Hoffmann M.; Sotriffer C.; Monti B.; Maurice T.; Decker M., Melatonin- And Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects in Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model, «JOURNAL OF MEDICINAL CHEMISTRY», 2021, 64, pp. 3794 - 3812 [articolo]Open Access

Gorecki L.; Uliassi E.; Bartolini M.; Janockova J.; Hrabinova M.; Hepnarova V.; Prchal L.; Muckova L.; Pejchal J.; Karasova J.Z.; Mezeiova E.; Benkova M.; Kobrlova T.; Soukup O.; Petralla S.; Monti B.; Korabecny J.; Bolognesi M.L., Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease, «ACS CHEMICAL NEUROSCIENCE», 2021, 12, pp. 1698 - 1715 [articolo]Open Access

Scheiner M.; Hoffmann M.; He F.; Poeta E.; Chatonnet A.; Monti B.; Maurice T.; Decker M., Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy in Vitro and in Vivo in an Alzheimer's Disease Mouse Model, «JOURNAL OF MEDICINAL CHEMISTRY», 2021, 64, pp. 9302 - 9320 [articolo]

Monti B., p57kip2 nuclear export as a marker of oligodendrocytes differentiation: Towards an innovative phenotyping screening for the identification of myelin repair drugs, «EBIOMEDICINE», 2021, 66, Article number: 103298, pp. 1 - 2 [articolo]Open Access

Marques C.S.; Lopez O.; Bagetta D.; Carreiro E.P.; Petralla S.; Bartolini M.; Hoffmann M.; Alcaro S.; Monti B.; Bolognesi M.L.; Decker M.; Fernandez-Bolanos J.G.; Burke A.J., N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study, «BIOORGANIC CHEMISTRY», 2020, 98, Article number: 103753, pp. 103753 - 103765 [articolo]

Rossi M.; Petralla S.; Protti M.; Baiula M.; Kobrlova T.; Soukup O.; Spampinato S.M.; Mercolini L.; Monti B.; Bolognesi M.L., α-linolenic acid-valproic acid conjugates: Toward single-molecule polypharmacology for multiple sclerosis, «ACS MEDICINAL CHEMISTRY LETTERS», 2020, 11, pp. 2406-2413 - 2413 [articolo]Open Access

Uliassi, Elisa; Pena-Altamira, Luis Emiliano; Morales, Aixa V.; Massenzio, Francesca; Petralla, Sabrina; Rossi, Michele; Roberti, Marinella; Martinez Gonzalez, Loreto; Martinez, Ana; Monti, Barbara; Bolognesi, Maria Laura*, A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential, «ACS CHEMICAL NEUROSCIENCE», 2019, 10, pp. 279 - 294 [articolo]

Ultimi avvisi

Al momento non sono presenti avvisi.